Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ionis Pharmaceuticals (IONS)
NASDAQ:IONS
Ionis Pharmaceuticals (IONS) Ownership - Who Owns Ionis Pharmaceuticals?
1,232 Followers
Ionis Pharmaceuticals (IONS) Ownership Overview
2.95% Insiders
38.26% Mutual Funds
14.46% Other Institutional Investors
44.33% Public Companies and
Individual Investors
The ownership structure of Ionis Pharmaceuticals (IONS) stock is a mix of institutional, retail and individual investors. Approximately 52.72% of the company’s stock is owned by Institutional Investors, 2.95% is owned by Insiders and 44.33% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 16, 2024 | Brett Monia Ceo Level 15,director | Sold | $17218 |
| Feb 02, 2024 | Eric Swayze Officer Level 14 | Sold | $560196 |
| Jan 29, 2024 | Brett Monia Ceo Level 15,director | Sold | $118249 |
| Jan 29, 2024 | Patrick O'neil Evp Clo & Gc | Sold | $333788 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $708 | |
| Dec 31, 2023 | Bought | $44418 | |
| Dec 31, 2023 | Sold | $353573 | |
| Dec 31, 2023 | Sold | $633639 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,795,397 | Institution | 8.09% | 490,098,745 | |
| 11,711,733 | Institution | 8.04% | 486,622,506 | |
| 11,467,444 | Institution | 7.87% | 476,472,298 | |
| 4,714,200 | Institution | 3.23% | 195,875,010 | |
| 3,963,733 | Institution | 2.72% | 164,693,106 | |
| 3,454,676 | Institution | 2.37% | 143,541,788 | |
| 3,063,073 | Institution | 2.10% | 127,270,683 | |
| 2,954,743 | Institution | 2.03% | 122,769,572 | |
| 2,276,417 | Institution | 1.56% | 94,585,126 | |
| 1,905,056 | Institution | 1.31% | 79,155,077 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,795,397 | Institution | 8.09% | 490,098,745 | |
| 11,467,444 | Institution | 7.87% | 476,472,298 | |
| 4,714,200 | Institution | 3.23% | 195,875,010 | |
| 3,063,073 | Institution | 2.10% | 127,270,683 | |
| 2,954,743 | Institution | 2.03% | 122,769,572 | |
| 2,276,417 | Institution | 1.56% | 94,585,126 | |
| 1,757,237 | Institution | 1.21% | 73,013,197 | |
| 1,398,857 | Institution | 0.96% | 58,122,508 | |
| 1,360,598 | Institution | 0.93% | 56,532,847 | |
| 1,272,474 | Institution | 0.87% | 52,871,295 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,965,464 | Institution | 2.72% | 171,902,864 | |
| 3,160,348 | Institution | 2.17% | 137,001,086 | |
| 2,146,139 | Institution | 1.47% | 93,035,126 | |
| 1,789,696 | Institution | 1.23% | 77,583,322 | |
| 1,667,282 | Institution | 1.14% | 69,275,567 | |
| 1,351,815 | Institution | 0.93% | 56,167,913 | |
| 993,091 | Institution | 0.68% | 41,262,931 | |
| 675,602 | Institution | 0.46% | 28,199,627 | |
| 565,234 | Institution | 0.39% | 23,485,473 | |
| 440,137 | Institution | 0.30% | 19,079,939 |
FAQ
Who Owns Ionis Pharmaceuticals (IONS)?
According to the latest TipRanks data, approximately 14.46% of the company's stock is held by institutional investors, 2.95% is held by insiders, and 44.33% is held by retail investors.
What percentage of Ionis Pharmaceuticals (IONS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 14.46% of Ionis Pharmaceuticals (IONS) stock is held by institutional investors.
What percentage of Ionis Pharmaceuticals (IONS) stock is held by retail investors?
According to the latest TipRanks data, approximately 44.33% of Ionis Pharmaceuticals (IONS) stock is held by retail investors.
Who owns the most shares of Ionis Pharmaceuticals (IONS)?
VANGUARD INDEX FUNDS owns the most shares of Ionis Pharmaceuticals (IONS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.